Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2006 / Cilt: 12 - Sayı: 1

İnsan karaciğer pirüvat kinazının saflaştırılması ve kinetik özellikleri

Purification and kinetic properties of human liver pyruvate kinase

Pages
17–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Km values for PEP and ADP were 1.2 and 0.3 mM respectively. 2,3-DPG and ATP were found to initially activate and subsequently inhibit the enzyme, as the concentration of 2,3-DPG and ATP increased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The kinetic properties of pyruvate kinase purified from human liver were investigated.
📊
Key Findings & Data:Human liver pyruvate kinase was purified by three-step process involving ammonium sulphate precipitation, dialysis and Sephadex G-200 chromatography.
💡
Conclusion & Impact:The Km values for PEP and ADP were 1.2 and 0.3 mM respectively. 2,3-DPG and ATP were found to initially activate and subsequently inhibit the enzyme, as the concentration of 2,3-DPG and ATP increased.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:pirüvat kinaz · karaciğer · insan hastalıkları

Abstract

The kinetic properties of pyruvate kinase purified from human liver were investigated. Human liver pyruvate kinase was purified by three-step process involving ammonium sulphate precipitation, dialysis and Sephadex G-200 chromatography. L type of pyruvate kinase enzyme was able to be purified about 26.3-fold with 13.2% yield in human liver. Specific activity of the enzyme was found to be 2.6 U/mg protein. The optimal pH for human liver pyruvate kinase was found to be 7.4. K+, Mg2+, Mn2+ and Na+ ions activated enzyme whereas Ca2+ ions inhibited it. The enzyme was regulated by FDP, ADP and pyruvate kinase activity was inhibited by alanine. The Km values for PEP and ADP were 1.2 and 0.3 mM respectively. 2,3-DPG and ATP were found to initially activate and subsequently inhibit the enzyme, as the concentration of 2,3-DPG and ATP increased.

Özet

İnsan karaciğer pirüvat kinazı saflaştırılarak kinetik özellikleri araştırılmıştır. İnsan karaciğer pirüvat kinazı amonyum sülfat ile çöktürme, dializ ve Sefadex G-200 kromatografiyi içeren 3 safha ile saflaştırılmıştır. L tip pirüvat kinaz enzimi insan karaciğer dokusunda %13.2 ürünle yaklaşık 26.3 kat saflaştırılabilmiştir. Enzimin spesifik aktivitesi 2.6 U/mg protein bulunmuştur. İnsan karaciğer pirüvat kinazı için optimal pH 7.4 olarak saptanmıştır. Ca+2 iyonu enzimi inhibe, K+, Mg+2, Mn+2 ve Na+ iyonları ise aktive etmiştir. Pirüvat kinaz FDP, ADP ile düzenlenmiş, alanın ile inhibe edilmiştir. PEP ve ADP için Km değerleri sırası ile 1.2 ve 0.3 mM bulunmuştur. 2,3-DPG ve ATP konsantrasyon artışına bağlı olarak başlangıçta enzimi aktive daha sonra inhibe etmiştir.

🔖

Cite This Article

YILMAZ, S., İLHAN, N. (2006). İnsan karaciğer pirüvat kinazının saflaştırılması ve kinetik özellikleri. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 12 - Sayı: 1, 17–23. https://ajindex.com/articles/274195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Terlecki G: Purification and properties of pyruvate kinase type Ml from bovine brain. Int J Biochem, 21, 1053-1060, 1989.
  2. Yılmaz S, Üstündağ B: The levels of pyruvate kinase activity in renal and hepatic tissues of rats with diabetes induced by streptozotocin. Turk J Vet Anim Sci, 26, 549- 553, 2002. Ekdahl KN: Studies on the regulation of rat liver pyruvate kinase and fructose-1, 6-bisphosphase. Ups J Med Sci, 92, 217-232, 1987. Muirhead H: Isoenzymes of pyruvate kinase. Biochem Soc Trans, 18, 193-196, 1990.
  3. Kiffmeyer WR, Farrar WW: Purification and properties of pig heart pyruvate kinase. / Protein Chem, 10, 585-591, 1991.
  4. Cuenllas E, Gaitan S, Bueren JA, Tejero C: Kinetic studies of pyruvate kinase during in vitro differentiation of GM-CFC haernopoietic precursor and bone marrow cells in mice. BiosciRep, 10, 141-154, 1990.
  5. Heinrichs M, Jacobasch G, Scheiner-Bobis K, Bertram S, Eigenbrodt E, Reinacher M: Human erythrocyte pyruvate kinase (L'/R-pyruvate kinase): Production and characterization of a monoclonal antibody. Biomed Biochim Ada, 46 (2/3): 223-228, 1987.
  6. Parkinson C, Ashizawa K, Mcphie P, Lin K, Cheng S: The monomer of pyruvate kinase, subtype Ml, is both a kinase and a cytosolic thyroid hormone binding protein. Biochem Biophys Res Commun, 179, 668-674, 1991.
  7. Kahn A, Marie J, Boivin P: Pyruvate kinase isoenzymes in man. Hum Genet, 33, 35-46, 1976.
  8. Wimmer M, Luttringer C, Colombi M: Enzyme activity patterns of phosphoenolpyruvate carboxykinase, pyruvate kinase, glucose-6-phosphate-dehydrogenase and malic enzyme in human liver. Histochemistry, 93, 409-415, 1990. Storey KB: Regulation of liver metabolism by enzyme phosphorylation during mammalian hibernation. J Biol Chem, 262 (4): 1670-1673, 1987.
  9. Plested CP, Taylor E, Brindley DN, Vernon RG: interactions of insulin and dexamethasone in the control of pyruvate kinase activity and glucose metabolism in sheep adipose tissue. J Biochem, 247, 459-465, 1987.
  10. Beutler E, Blume KG, Kaplan JC, Löhr GW, Ramot B, Valentine WN: International committee for standardization in haematology. Recommended methods for the characterization of red cell pyruvate kinase variants. British J Haematol, 43,275-286,1979.
  11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol regent. J Biol Chem, 193,265-275, 1951.
  12. Kedryna T, Guminska M, Marchut E: Pyruvate Kinase from cytosolic fractions of the Ehrlich ascites tumour, normal mouse liver and skeletal muscle. Biochim Biophys Acta,.VS9, 130-133, 19